참고문헌
- Afanas'ev I (2011). Reactive oxygen species signaling in cancer: comparison with aging. Aging Disease, 2, 219.
- Algotar AM, Stratton MS, Ahmann F, et al (2013). Phase 3 clinical trial investigating the effect of selenium supplementation in men at high-risk for prostate cancer. Prostate, 73, 328-35. https://doi.org/10.1002/pros.22573
- Allan CB, Lacourciere GM, Stadtman TC (1999). Responsiveness of selenoproteins to dietary selenium 1, 2. Ann Review Nutrit, 19, 1-16. https://doi.org/10.1146/annurev.nutr.19.1.1
- Behrens W, Thompson J, Madere R (1982). Distribution of alpha-tocopherol in human plasma lipoproteins. Am J Clin Nutrit, 35, 691-6.
- Bhagat SS, Ghone RA, Suryakar AN, et al (2011). Lipid peroxidation and antioxidant vitamin status in colorectal cancer patients. Indian J Physiol Pharmacol, 55, 72-6.
- Bidoli E, Talamini R, Zucchetto A, et al (2009). Dietary vitamins E and C and prostate cancer risk. Acta Oncologica, 48, 890-4. https://doi.org/10.1080/02841860902946546
- Brawley OW (2012). Prostate cancer epidemiology in the United States. World J Urol, 30, 195-200. https://doi.org/10.1007/s00345-012-0824-2
- Brown K, Arthur J (2001). Selenium, selenoproteins and human health: a review. Public Health Nutrit, 4, 593-9.
- Burton GW (1994). Vitamin E: molecular and biological function. Proceedings Nutrit Soc, 53, 251-62. https://doi.org/10.1079/PNS19940030
- Catalona WJ, Smith DS, Ratliff TL, et al (1991). Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. New Engl J Med, 324, 1156-61. https://doi.org/10.1056/NEJM199104253241702
- CDC. 2014. Cancer Prevention and Control [Online]. Available: http://www.cdc.gov/cancer/dcpc/data/men.htm [Accessed October 12 2014].
- Cheng W-H, Wu RT, Wu M, et al (2012). Targeting werner syndrome protein sensitizes U-2 OS osteosarcoma cells to selenium-induced DNA damage response and necrotic death. Biochem Biophys Res Comm, 420, 24-8. https://doi.org/10.1016/j.bbrc.2012.02.104
- Deneo-Pellegrini H, De Stefani E, Ronco A, et al (1999). Foods, nutrients and prostate cancer: a case-control study in Uruguay. Br J Cancer, 80, 591. https://doi.org/10.1038/sj.bjc.6690396
- Dodig S, Cepelak I (2004). The facts and controversies about selenium. Acta Pharm, 54, 261-76.
- Duffield-Lillico A, Dalkin B, Reid M, et al (2003). Selenium supplementation, baseline plasma selenium status and incidence of prostate cancer: an analysis of the complete treatment period of the nutritional prevention of cancer trial. BJU International, 91, 608-12. https://doi.org/10.1046/j.1464-410X.2003.04167.x
- Farrell PM, Bieri JG (1975). Megavitamin E supplementation in man. Am J Clin Nutr, 28, 1381-6.
- Fleshner NE, Kapusta L, Donnelly B, et al (2011). Progression from high-grade prostatic intraepithelial neoplasia to cancer: a randomized trial of combination vitamin-E, soy, and selenium. J Clin Oncol, 29, 2386-90. https://doi.org/10.1200/JCO.2010.32.0994
-
Ford ES, Sowell A (1999). Serun
${\alpha}$ -Tecopherol status in the United States population: findings from the third national health and nutrition examination survey. Am J Epidemiol, 150, 290-300. https://doi.org/10.1093/oxfordjournals.aje.a010001 - Fuchs-Tarlovsky V, Bejarano-Rosales M, Gutierrez-Salmean G, et al (2010). [Effect of antioxidant supplementation over oxidative stress and quality of life in cervical cancer]. Nutricion Hospitalaria, 26, 819-26.
- Gaziano JM, Glynn RJ, Christen WG, et al (2009). Vitamins E and C in the prevention of prostate and total cancer in men: the physicians' health study II randomized controlled trial. JAMA, 301, 52-62.
- Group HPSC (2002). MRC/BHF heart protection study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet, 360, 23. https://doi.org/10.1016/S0140-6736(02)09328-5
- Gupta-Elera G, Garrett AR, Robison RA, et al (2012). The role of oxidative stress in prostate cancer. Eur J Cancer Prev, 21, 155-62. https://doi.org/10.1097/CEJ.0b013e32834a8002
- Hartman TJ, Albanes D, Pietinen P, et al (1998). The association between baseline vitamin E, selenium, and prostate cancer in the alpha-tocopherol, beta-carotene cancer prevention study. Cancer Epidemiol Biomarkers Prev, 7, 335-40.
- He K (2011). Trace elements in nails as biomarkers in clinical research. European J Clin Investigat, 41, 98-102. https://doi.org/10.1111/j.1365-2362.2010.02373.x
-
Heinonen OP, Koss L, Albanes D, et al (1998). Prostate cancer and supplementation with
${\alpha}$ -tocopherol and${\beta}$ -carotene: incidence and mortality in a controlled trial. J Natl Cancer Inst, 90, 440-6. https://doi.org/10.1093/jnci/90.6.440 - Ho E, Beaver LM, Williams DE, et al (2011). Dietary factors and epigenetic regulation for prostate cancer prevention. advances in nutrition: Intern Rev J, 2, 497-510.
- Hodge AM, English DR, McCredie MR, et al (2004). Foods, nutrients and prostate cancer. Cancer Causes Control, 15, 11-20. https://doi.org/10.1023/B:CACO.0000016568.25127.10
- Horwitt M (1960). Vitamin E and lipid metabolism in man. Am J Clin Nutrit, 8, 451-61.
- Ide H, Lu Y, Yu J, et al (2012). Testosterone promotes DNA damage response under oxidative stress in prostate cancer cell lines. Prostate, 72, 1407-11. https://doi.org/10.1002/pros.22492
- Kheirandish P, Chinegwundoh F (2011). Ethnic differences in prostate cancer. Br J Cancer, 105, 481-5. https://doi.org/10.1038/bjc.2011.273
- Kim J-E, Han M, Hanl K-S, et al (2011). Vitamin E inhibition on platelet procoagulant activity: Involvement of aminophospholipid translocase activity. Thrombosis Res, 127, 435-42. https://doi.org/10.1016/j.thromres.2011.01.007
-
Kirsh VA, Hayes RB, Mayne ST, et al (2006). Supplemental and dietary vitamin E,
${\beta}$ -carotene, and vitamin C intakes and prostate cancer risk. J Natl Cancer Inst, 98, 245-54. https://doi.org/10.1093/jnci/djj050 - Klein E, Thompson I, Lippman S, et al (2000). SELECT: the selenium and Vitamin E Cancer prevention trial: rationale and design. Prostate Cancer Prostatic Diseases, 3, 145-51. https://doi.org/10.1038/sj.pcan.4500412
- Klein EA, Thompson IM, Tangen CM, et al (2011). Vitamin E and the risk of prostate cancer: the selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA, 306, 1549-56. https://doi.org/10.1001/jama.2011.1437
- Kristal AR, Darke AK, Morris JS, et al (2014). Baseline selenium status and effects of selenium and vitamin E supplementation on prostate cancer risk. J Natl Cancer Inst, 106, djt456. https://doi.org/10.1093/jnci/djt456
- Laranjinha J, Vieira Ol, Madeira Vt, et al (1995). Two related phenolic antioxidants with opposite effects on vitamin E content in low density lipoproteins oxidized by ferrylmyoglobin: consumption vs regeneration. Arch Biochem Biophys, 323, 373-81. https://doi.org/10.1006/abbi.1995.0057
- Lawal A, Kolude B, Adeyemi B, et al (2012). Serum antioxidant vitamins and the risk of oral cancer in patients seen at a tertiary institution in Nigeria. Nigerian J Clin Practice, 15.
- Lemire M, Philibert A, Fillion M, et al (2012). No evidence of selenosis from a selenium-rich diet in the Brazilian Amazon. Environment Int, 40, 128-36. https://doi.org/10.1016/j.envint.2011.07.005
- Levander OA (1997). Selenium requirements as discussed in the 1996 joint FAO/IAEA/WHO expert consultation on trace elements in human nutrition. Biomed Environment Sci, 10, 214-9.
- Ling MT, Luk SU, Al-Ejeh F, et al (2012). Tocotrienol as a potential anticancer agent. Carcinogenesis, 33, 233-9. https://doi.org/10.1093/carcin/bgr261
- Liu J-G, Zhao H-J, Liu Y-J, et al (2012). Effect of two selenium sources on hepatocarcinogenesis and several angiogenic cytokines in diethylnitrosamine-induced hepatocarcinoma rats. J Trace Elements Med Biology, 26, 255-61. https://doi.org/10.1016/j.jtemb.2012.02.001
- Lonn E, Bosch J, Yusuf S, et al (2005). Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial. JAMA, 293, 1338-47. https://doi.org/10.1001/jama.293.11.1338
- Marshall JR, Tangen CM, Sakr WA, et al (2011). Phase III trial of selenium to prevent prostate cancer in men with high-grade prostatic intraepithelial neoplasia: SWOG S9917. Cancer Prev Res, 4, 1761-9. https://doi.org/10.1158/1940-6207.CAPR-10-0343
- McCann SE, Ambrosone CB, Moysich KB, et al (2005). Intakes of selected nutrients, foods, and phytochemicals and prostate cancer risk in western New York. Nutrit Cancer, 53, 33-41. https://doi.org/10.1207/s15327914nc5301_4
- Meyer F, Galan P, Douville P, et al (2005). Antioxidant vitamin and mineral supplementation and prostate cancer prevention in the SU. VI. MAX trial. Int J Cancer, 116, 182-6. https://doi.org/10.1002/ijc.21058
- Miller AB (2012). New data on prostate-cancer mortality after PSA screening. N Engl J Med, 366, 1047-8. https://doi.org/10.1056/NEJMe1200185
- Morris MC, Beckett LA, Scherr PA, et al (1998). Vitamin E and vitamin C supplement use and risk of incident Alzheimer disease. Alzheimer Dis Assoc Dis, 12, 121-6. https://doi.org/10.1097/00002093-199809000-00001
- Muir C, Nectoux J, Staszewski J (1991). The epidemiology of prostatic cancer: geographical distribution and time-trends. Acta Oncol, 30, 133-40. https://doi.org/10.3109/02841869109092336
- Neve J (1991). Methods in determination of selenium states. J Trace Elements Electrolytes Health Disease, 5, 1-17.
- NIH. 2013. Vitamin E fact sheet for health professionals [Online]. Available: http://ods.od.nih.gov/factsheets/VitaminE-HealthProfessional/ [Accessed September 14 2014].
- Powell IJ, Banerjee M, Sakr W, et al (1999). Should African-American men be tested for prostate carcinoma at an earlier age than white men? Cancer, 85, 472-7. https://doi.org/10.1002/(SICI)1097-0142(19990115)85:2<472::AID-CNCR27>3.0.CO;2-0
- Redman C, Scott JA, Baines AT, et al (1998). Inhibitory effect of selenomethionine on the growth of three selected human tumor cell lines. Cancer Letters, 125, 103-10. https://doi.org/10.1016/S0304-3835(97)00497-7
- Ripple MO, Hagopian K, Oberley TD, et al (1999). Androgen-induced oxidative stress in human LNCaP prostate cancer cells is associated with multiple mitochondrial modifications. Antioxidants Redox Signal, 1, 71-81. https://doi.org/10.1089/ars.1999.1.1-71
- Rodriguez C, Jacobs EJ, Mondul AM, et al (2004). Vitamin E supplements and risk of prostate cancer in US men. Cancer Epidemiology Biomarkers Prev, 13, 378-82.
- Roemeling S, Roobol MJ, Kattan MW, et al (2007). Nomogram use for the prediction of indolent prostate cancer. Cancer, 110, 2218-21. https://doi.org/10.1002/cncr.23029
- Sakr W, Grignon D, Haas G (1998). Pathology of premalignant lesions and carcinoma of the prostate in African-American men. Sem Urol Oncol, 16, 214-20.
- Schroder FH, Hugosson J, Roobol MJ, et al (2009). Screening and prostate-cancer mortality in a randomized European study. New Engl J Med, 360, 1320-8. https://doi.org/10.1056/NEJMoa0810084
- Schuurman AG, Goldbohm RA, Brants HA, et al (2002). A prospective cohort study on intake of retinol, vitamins C and E, and carotenoids and prostate cancer risk (Netherlands). Cancer Causes Control, 13, 573-82. https://doi.org/10.1023/A:1016332208339
- Shimizu H, Ross R, Bernstein L, et al (1991). Cancers of the prostate and breast among Japanese and white immigrants in Los Angeles County. Br J Cancer, 63, 963-6. https://doi.org/10.1038/bjc.1991.210
- Steyerberg E, Roobol M, Kattan M, et al (2007). Prediction of indolent prostate cancer: validation and updating of a prognostic nomogram. J Urology, 177, 107-12. https://doi.org/10.1016/j.juro.2006.08.068
- Swanson C, Patterson B, Levander O, et al (1991). Human [74Se] selenomethionine metabolism: a kinetic model. Am J Clin Nutrit, 54, 917-26.
- Thompson Jr IM, Goodman PJ, Tangen CM, et al (2013). Long-term survival of participants in the prostate cancer prevention trial. New Engl J Med, 369, 603-10. https://doi.org/10.1056/NEJMoa1215932
-
Torricelli P, Caraglia M, Abbruzzese A, et al (2013).
${\gamma}$ -Tocopherol inhibits human prostate cancer cell proliferation by up-regulation of transglutaminase 2 and down-regulation of cyclins. Amino Acids, 44, 45-51. https://doi.org/10.1007/s00726-012-1278-y - Vatassery G, Krezowski A, Eckfeldt J (1983). Vitamin E concentrations in human blood plasma and platelets. Am J Clin Nutrition, 37, 1020-4.
- Venkateswaran V, Klotz LH (2010). Diet and prostate cancer: mechanisms of action and implications for chemoprevention. Nature Reviews Urology, 7, 442-53. https://doi.org/10.1038/nrurol.2010.102
- Virtamo J, Pietinen P, Huttunen J, et al (2003). Incidence of cancer and mortality following alpha-tocopherol and beta-carotene supplementation: a postintervention follow-up. JAMA, 290, 476-85. https://doi.org/10.1001/jama.290.4.476
- Vlajinac H, Marinkovic J, Ilic M, et al (1997). Diet and prostate cancer: a case-control study. Eur J Cancer, 33, 101-7. https://doi.org/10.1016/S0959-8049(96)00373-5
-
Vykhovanets EV, Shankar E, Vykhovanets OV, et al (2011). High-fat diet increases NF-
${\kappa}B$ signaling in the prostate of reporter mice. Prostate, 71, 147-56. https://doi.org/10.1002/pros.21230 - Weinstein SJ, Wright ME, Lawson KA, et al (2007). Serum and dietary vitamin E in relation to prostate cancer risk. Cancer Epidemiology Biomarkers Prev, 16, 1253-9. https://doi.org/10.1158/1055-9965.EPI-06-1084
- Wen Y, Killalea S, Norris L, et al (1999). Vitamin E supplementation in hyperlipidaemic patients: effect of increasing doses on in vitro and in vivo low-density lipoprotein oxidation. Euro J Clin Investigation, 29, 1027-34. https://doi.org/10.1046/j.1365-2362.1999.00579.x
- West DW, Slattery ML, Robison LM, et al (1991). Adult dietary intake and prostate cancer risk in Utah: a case-control study with special emphasis on aggressive tumors. Cancer Causes Control, 2, 85-94. https://doi.org/10.1007/BF00053126
- WHO (2008). World cancer factsheet [Online]. Available: http://gicr.iarc.fr/files/resources/20120906-WorldCancerFactSheet.pdf [Accessed September 7 2014].
- Wright ME, Weinstein SJ, Lawson KA, et al (2007). Supplemental and dietary vitamin E intakes and risk of prostate cancer in a large prospective study. Cancer Epidemiol Biomarkers Prev, 16, 1128-35. https://doi.org/10.1158/1055-9965.EPI-06-1071
- Wu M, Kang MM, Schoene NW, et al (2010). Selenium compounds activate early barriers of tumorigenesis. J Biological Chemistry, 285, 12055-62. https://doi.org/10.1074/jbc.M109.088781
- Wu M, Wu RT, Wang TT, et al (2011). Role for p53 in selenium-induced senescence. J Agricultural Food Chemistry, 59, 11882-7. https://doi.org/10.1021/jf203012a
- Xia S-J, Cui D, Jiang Q (2012). An overview of prostate diseases and their characteristics specific to Asian men. Asian J Andrology, 14, 458. https://doi.org/10.1038/aja.2010.137
- Xia Y, Hill KE, Burk RF (1989). Biochemical studies of a selenium-deficient population in China: measurement of selenium, glutathione peroxidase and other oxidant defense indices in blood. J Nutrit, 119, 1318-26.
- Yang L, Pascal M, Wu XH (2013). Review of selenium and prostate cancer prevention. Asian Pac J Cancer Prev, 14, 2181-4. https://doi.org/10.7314/APJCP.2013.14.4.2181
- Yoshizawa K, Willett WC, Morris SJ, et al (1998). Study of prediagnostic selenium level in toenails and the risk of advanced prostate cancer. J Natl Cancer Inst, 90, 1219-24. https://doi.org/10.1093/jnci/90.16.1219
피인용 문헌
- Selenium and Human Health: Witnessing a Copernican Revolution? vol.33, pp.3, 2015, https://doi.org/10.1080/10590501.2015.1055163
- Effect of vitamin E supplementation on uterine cervical neoplasm: A meta-analysis of case-control studies vol.12, pp.8, 2017, https://doi.org/10.1371/journal.pone.0183395
- Treatment of steroid-induced osteonecrosis of the femoral head using porous Se@SiO2 nanocomposites to suppress reactive oxygen species vol.7, pp.2045-2322, 2017, https://doi.org/10.1038/srep43914